![Madhavan Balachandran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Madhavan Balachandran
Directeur/Bestuurslid bij
UNIQURE N.V.
Vermogen: 5 M $ op 31-08-2026
Profiel
Momenteel bekleedt Madhavan Balachandran de functie van Chief Operating Officer bij Brentwood Press & Publishing Co. en Chief Operating Officer bij Nutcracker Therapeutics, Inc. De heer Balachandran zit ook in de raad van bestuur van 5 andere bedrijven. In het verleden was de heer Balachandran Chief Executive Officer & Director bij ADRx, Inc., Executive Vice President bij Amgen, Inc., Vice President-Engineering bij Glaxo Wellcome, Inc., Principal bij Battelle Memorial Institute en Vice President bij Puerto Rico USA Citizenship Foundation. Hij behaalde een MBA aan de East Carolina University, een doctoraal aan het Indian Institute of Technology Bombay en een doctoraal aan de State University van New York in Buffalo.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
UNIQURE N.V. 0,07% | 17-06-2026 | 43.254 ( 0,07% ) | 2 M $ | 31-08-2026 |
| 15-06-2026 | 69.458 ( 0,03% ) | 1 M $ | 31-08-2026 | |
STEVANATO GROUP SPA 0,13% | 31-12-2025 | 65.976 ( 0,13% ) | 1 M $ | 31-08-2026 |
| 30-06-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Madhavan Balachandran
| Bedrijven | Functie | Begin |
|---|---|---|
| UNIQURE N.V. | Directeur/Bestuurslid | 14-09-2017 |
| STEVANATO GROUP S.P.A. | Directeur/Bestuurslid | 01-09-2018 |
| REPLIMUNE GROUP, INC. | Directeur/Bestuurslid | 05-09-2024 |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Develops medicine for treatment of neurodegenerative diseases and neurotrauma | Directeur/Bestuurslid | 01-06-2018 |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. BiotechnologyHealth Technology Provides end-to-end RNA therapeutics research and development services | Corporate Officer/Principal | 23-09-2020 |
Brentwood Press & Publishing Co.
 Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Publishes newspapers | Operationeel Directeur | 23-09-2020 |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Directeur/Bestuurslid | - |
Eerdere bekende functies van Madhavan Balachandran
| Bedrijven | Functie | Einde |
|---|---|---|
| CATALENT, INC. | Directeur/Bestuurslid | 25-01-2024 |
ADRx, Inc.
 ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Algemeen Directeur | 01-10-2020 |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Madhavan Balachandran
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
83
Eerstegraads connecties
16
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization for science and technology research & development | Commercial Services |
East Carolina University
 East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brentwood Press & Publishing Co.
Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Publishes newspapers | Consumer Services |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Puerto Rico USA Citizenship Foundation | |
Stevanato Group SpA
 Stevanato Group SpA Medical SpecialtiesHealth Technology Designs, manufacturers and supplies glass bottles and glass tube containers | Health Technology |
Indian Institute of Technology Bombay
 Indian Institute of Technology Bombay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
uniQure NV
 uniQure NV BiotechnologyHealth Technology Engages in the discovery, development and commercialization of gene therapies products | Health Technology |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Develops medicine for treatment of neurodegenerative diseases and neurotrauma | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Commercial Services |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. BiotechnologyHealth Technology Provides end-to-end RNA therapeutics research and development services | Health Technology |
ADRx, Inc.
ADRx, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology drug discovery company focused on developing small-molecule therapies for neurodegenerative diseases | Commercial Services |
